LY3025876

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY3025876, covering 2018-07-16 to 2019-01-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3025876 in Participants With Diabetes [Phase 1]